Tissue-resident memory CD8


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2019
Historique:
received: 04 05 2018
accepted: 01 11 2018
pubmed: 2 1 2019
medline: 16 7 2019
entrez: 2 1 2019
Statut: ppublish

Résumé

The immune system can suppress tumour development both by eliminating malignant cells and by preventing the outgrowth and spread of cancer cells that resist eradication

Identifiants

pubmed: 30598548
doi: 10.1038/s41586-018-0812-9
pii: 10.1038/s41586-018-0812-9
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-371

Subventions

Organisme : Medical Research Council
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : ErratumIn
Type : CommentIn
Type : CommentIn

Références

Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).
doi: 10.1126/science.1203486
MacKie, R. M., Reid, R. & Junor, B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N. Engl. J. Med. 348, 567–568 (2003).
doi: 10.1056/NEJM200302063480620
Koebel, C. M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903–907 (2007).
doi: 10.1038/nature06309
Teng, M. W. et al. Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Res. 72, 3987–3996 (2012).
doi: 10.1158/0008-5472.CAN-12-1337
Wylie, B. et al. Cross-presentation of cutaneous melanoma antigen by migratory XCR1
doi: 10.1080/2162402X.2015.1019198
Gebhardt, T. et al. Different patterns of peripheral migration by memory CD4
doi: 10.1038/nature10339
Jiang, X. et al. Skin infection generates non-migratory memory CD8
doi: 10.1038/nature10851
Gebhardt, T. et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nature Immunol. 10, 524–530 (2009).
doi: 10.1038/ni.1718
Ariotti, S. et al. Tissue-resident memory CD8
doi: 10.1073/pnas.1208927109
Mackay, L. K. et al. Long-lived epithelial immunity by tissue-resident memory T (T
doi: 10.1073/pnas.1202288109
Gebhardt, T., Palendira, U., Tscharke, D. C. & Bedoui, S. Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance. Immunol. Rev. 283, 54–76 (2018).
doi: 10.1111/imr.12650
Enamorado, M. et al. Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8
doi: 10.1038/ncomms16073
Malik, B. T. et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci. Immunol. 2, eaam6346 (2017).
doi: 10.1126/sciimmunol.aam6346
Murray, T. et al. Very late antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients. Front. Immunol. 7, 573 (2016).
doi: 10.3389/fimmu.2016.00573
Boddupalli, C. S. et al. Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells. JCI Insight 1, e88955 (2016).
doi: 10.1172/jci.insight.88955
Salerno, E. P., Olson, W. C., McSkimming, C., Shea, S. & Slingluff, C. L. Jr T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins. Int. J. Cancer 134, 563–574 (2014).
doi: 10.1002/ijc.28391
Edwards, J. et al. CD103
doi: 10.1158/1078-0432.CCR-17-2257
Mackay, L. K. et al. The developmental pathway for CD103
doi: 10.1038/ni.2744
Schenkel, J. M., Fraser, K. A., Vezys, V. & Masopust, D. Sensing and alarm function of resident memory CD8
doi: 10.1038/ni.2568
Landsberg, J. et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490, 412–416 (2012).
doi: 10.1038/nature11538
Braumüller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361–365 (2013).
doi: 10.1038/nature11824
Webb, J. R., Milne, K., Watson, P., Deleeuw, R. J. & Nelson, B. H. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin. Cancer Res. 20, 434–444 (2014).
doi: 10.1158/1078-0432.CCR-13-1877
Djenidi, F. et al. CD8
doi: 10.4049/jimmunol.1402711
Wang, B. et al. CD103
doi: 10.1016/j.juro.2015.02.2941
Komdeur, F. L. et al. CD103
doi: 10.1080/2162402X.2017.1338230
Nizard, M. et al. Induction of resident memory T cells enhances the efficacy of cancer vaccine. Nat. Commun. 8, 15221 (2017).
doi: 10.1038/ncomms15221
Cockburn, I. A. et al. In vivo imaging of CD8
doi: 10.1073/pnas.1303858110
Halle, S. et al. In vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell cooperativity. Immunity 44, 233–245 (2016).
doi: 10.1016/j.immuni.2016.01.010
Zhu, J. et al. Immune surveillance by CD8αα
doi: 10.1038/nature12110
Woon, H. G. et al. Compartmentalization of total and virus-specific tissue-resident memory CD8
doi: 10.1371/journal.ppat.1005799
Mueller, S. N., Heath, W., McLain, J. D., Carbone, F. R. & Jones, C. M. Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80, 156–163 (2002).
doi: 10.1046/j.1440-1711.2002.01071.x
van Lint, A. et al. Herpes simplex virus-specific CD8
doi: 10.4049/jimmunol.172.1.392

Auteurs

Simone L Park (SL)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Anthony Buzzai (A)

Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.

Jai Rautela (J)

Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.
Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.

Jyh Liang Hor (JL)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Katharina Hochheiser (K)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Maike Effern (M)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.

Nathan McBain (N)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Teagan Wagner (T)

Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.

Jarem Edwards (J)

Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

Robyn McConville (R)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

James S Wilmott (JS)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

Richard A Scolyer (RA)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Thomas Tüting (T)

Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, Magdeburg, Germany.

Umaimainthan Palendira (U)

Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

David Gyorki (D)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia.

Scott N Mueller (SN)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
The Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Melbourne, Melbourne, Victoria, Australia.

Nicholas D Huntington (ND)

Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.
Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.

Sammy Bedoui (S)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Michael Hölzel (M)

Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.

Laura K Mackay (LK)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. lkmackay@unimelb.edu.au.
The Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Melbourne, Melbourne, Victoria, Australia. lkmackay@unimelb.edu.au.

Jason Waithman (J)

Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia. Jason.Waithman@telethonkids.org.au.

Thomas Gebhardt (T)

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. gebhardt@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH